Frederick F. Lang

Chairman, Department of Neurosurgery
MD Anderson Cancer Center

Disclosure: NO DISCLOSURE DATA

Presentation(s):

• TMIC-37 - Intercellular Communication between Normal and Tumor Cells in Glioma Microenvironment

  Friday, November 22
  2:40 PM – 2:45 PM

• EXTH-27 - Activating the immunity within the tumor using viroimmunotherapy: Delta-24-RGD oncolytic adenovirus armed with the immunopositive regulator GITRL

  Friday, November 22
  3:15 PM – 3:25 PM

• EXTH-11 - Treatment with Delta-24-RGDOX of subcutaneous tumors results in abscopal effect eradicating intracranial melanomas

  Friday, November 22
  4:35 PM – 4:40 PM

• EXTH-38 - Engineered exosomes for therapeutic gene delivery in brain tumors

  Friday, November 22
  7:30 PM – 9:30 PM

• EXTH-62 - Stem cell delivery of oncolytic adenovirus DNX-­2401 following surgical resection for the treatment of glioblastoma

  Friday, November 22
  7:42 PM – 7:46 PM

• TMIC-60 - Comprehensive spatial characterization of immune cells in the CNS brain tumor microenvironment

  Friday, November 22
  8:18 PM – 8:22 PM

• Principles of Viral Therapies Against Gliomas - Oncolytic and Immunological Aspects

  Saturday, November 23
  12:35 PM – 12:55 PM

• Trials of Oncolytic Viruses: The Impact of the Neurosurgeon

  Sunday, November 24
  7:00 AM – 7:20 AM

• ATIM-33 - Interim Results of a Phase II Multi-center Study of Oncolytic Adenovirus DNX-2401 with Pembrolizumab for Recurrent Glioblastoma; CAPTIVE Study (KEYNOTE-192)

  Sunday, November 24
  8:55 AM – 9:05 AM